117
Participants
Start Date
September 3, 2019
Primary Completion Date
March 2, 2021
Study Completion Date
November 30, 2021
Guselkumab 100 mg
Guselkumab 100 mg will be administered as SC injection.
Placebo
Placebo will be administered as SC injection.
Istituto Clinico Humanitas, Rozzano
MensingDerma research GmbH, Hamburg
Universitätsklinikum Schleswig Holstein Campus Lübeck, Lübeck
Hosp. Univ. Infanta Leonor, Madrid
Hosp. Univ. 12 de Octubre, Madrid
CHU Bordeaux - Hopital St Andre, Bordeaux
Hosp. Univ. I Politecni La Fe, Valencia
Hosp. de Manises, Valencia
Universitaetsklinikum Muenster, Münster
Fachklinik Bad Bentheim, Bad Bentheim
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Ospedale Santa Chiara AO Universitaria Pisana, Pisa
Centrovital, Witten
Universitatsklinikum Frankfurt, Frankfurt am Main
Hôpital Edouard Herriot, Lyon
Hopital Charles Nicolle, Rouen
P.O. Vittorio Emanuele Azienda Ospedaliero Universitaria 'Policlinico Vittorio Emanuele', Catania
CHU de Nice Hopital de l Archet, Nice
University Hospital Dresden, Dresden
AOU di Cagliari, Cagliari
Hosp. Univ. Germans Trias I Pujol, Badalona
Russell's Hall Hospital, Dudley
Chapel Allerton Hospital, Leeds
Barts Health NHS Trust, London
Royal Victoria Infirmary, Newcastle upon Tyne
Salford Royal NHS Foundation Trust, Salford
Janssen-Cilag Ltd.
INDUSTRY